These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7792330)

  • 21. [Executive and amnestic functions of a group of first-degree relatives of schizophrenic patients].
    Laurent A; d'Amato T; Naegele B; Murry P; Baro P; Foussard N; Spitz F; Dalery J
    Encephale; 2000; 26(5):67-74. PubMed ID: 11192806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology.
    Erlenmeyer-Kimling L; Cornblatt BA; Rock D; Roberts S; Bell M; West A
    Schizophr Bull; 1993; 19(1):141-53. PubMed ID: 8451608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosis proneness scales in schizophrenia spectrum personality disorders: familial vs. nonfamilial samples.
    Thaker G; Moran M; Adami H; Cassady S
    Psychiatry Res; 1993 Jan; 46(1):47-57. PubMed ID: 8464955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive dysfunctions in parents of schizophrenic patients parallel the deficits found in patients.
    Appels MC; Sitskoorn MM; Westers P; Lems E; Kahn RS
    Schizophr Res; 2003 Oct; 63(3):285-93. PubMed ID: 12957707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of the Continuous Performance Test among community samples.
    Chen WJ; Hsiao CK; Hsiao LL; Hwu HG
    Schizophr Bull; 1998; 24(1):163-74. PubMed ID: 9502554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perceptual aberrations, schizotypy, and the Wisconsin Card Sorting Test.
    Lenzenweger MF; Korfine L
    Schizophr Bull; 1994; 20(2):345-57. PubMed ID: 8085136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?
    Diwadkar VA; Montrose DM; Dworakowski D; Sweeney JA; Keshavan MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):230-8. PubMed ID: 16318899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A summary of attentional findings in the New York High-Risk Project.
    Erlenmeyer-Kimling L; Cornblatt BA
    J Psychiatr Res; 1992 Oct; 26(4):405-26. PubMed ID: 1491360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WCST performance and schizotypal features in the first-degree relatives of patients with schizophrenia.
    Laurent A; Duly D; Murry P; Foussard N; Boccara S; Mingat F; Dalery J; d'Amato T
    Psychiatry Res; 2001 Nov; 104(2):133-44. PubMed ID: 11711167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distractibility in schizophrenia: state and trait aspects.
    Spring B; Lemon M; Weinstein L; Haskell A
    Br J Psychiatry Suppl; 1989 Jul; (5):63-8. PubMed ID: 2605025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia.
    Matsui M; Sumiyoshi T; Kato K; Yoneyama E; Kurachi M
    Psychol Rep; 2004 Apr; 94(2):387-97. PubMed ID: 15154161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reaction time crossover in schizotypal subjects.
    Drewer HB; Shean GD
    J Nerv Ment Dis; 1993 Jan; 181(1):27-30. PubMed ID: 8419512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric detection of schizotypy: perceptual aberration and physical anhedonia in relatives of schizophrenics.
    Clementz BA; Grove WM; Katsanis J; Iacono WG
    J Abnorm Psychol; 1991 Nov; 100(4):607-12. PubMed ID: 1757676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficits in facial affect recognition in unaffected siblings of Xhosa schizophrenia patients: evidence for a neurocognitive endophenotype.
    Leppänen JM; Niehaus DJ; Koen L; Du Toit E; Schoeman R; Emsley R
    Schizophr Res; 2008 Feb; 99(1-3):270-3. PubMed ID: 18055176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Backward masking performance in unaffected siblings of schizophrenic patients. Evidence for a vulnerability indicator.
    Green MF; Nuechterlein KH; Breitmeyer B
    Arch Gen Psychiatry; 1997 May; 54(5):465-72. PubMed ID: 9152100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients.
    Cornblatt BA; Lenzenweger MF; Erlenmeyer-Kimling L
    Psychiatry Res; 1989 Jul; 29(1):65-85. PubMed ID: 2772099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological risk indicators for schizophrenia: a review of family studies.
    Kremen WS; Seidman LJ; Pepple JR; Lyons MJ; Tsuang MT; Faraone SV
    Schizophr Bull; 1994; 20(1):103-19. PubMed ID: 8197409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Event-related potentials in adolescents with schizophrenia and their siblings: a comparison with attention-deficit/hyperactivity disorder.
    Groom MJ; Bates AT; Jackson GM; Calton TG; Liddle PF; Hollis C
    Biol Psychiatry; 2008 Apr; 63(8):784-92. PubMed ID: 17977520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia.
    Purdon SE; Valiakalayil A; Hanstock CC; Seres P; Tibbo P
    Schizophr Res; 2008 Feb; 99(1-3):218-24. PubMed ID: 18248960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.